Blog

IVC,Filter,lawsuit,injury,lawyer,law,firm,stroke,death

Sheller PC is currently representing multiple victims nationwide injured by IVC filters. Below are just a few.  Currently 3,500 IVC Filter lawsuits are pending in the U.S. A Texas man will have to live
Various tablets

Patients with type 2 diabetes taking Johnson & Johnson’s drug Invokana are twice as likely to have a leg and foot amputation than patients given a placebo, two clinical trial show. The FDA
Screen Shot 2017-04-12 at 1.46.49 PM

On October 7, 2017, Stephen and Sandra Sheller will be honored by the National Liberty Museum as their 2017 “Heroes of Liberty” at the Glass Auction & Gala. This event will support the
IVC,Filter,lawsuit,injury,lawyer,law,firm,stroke,death

Here’s an update on our earlier post about IVC heart filter injuries. Sheller, P.C. medical device attorneys continue to investigate injuries and deaths related to the IVC Blood Filters and are available to
Various tablets

Sheller, P.C. attorneys are investigating the newer class of diabetes drugs following FDA warnings. ABOUT THE DRUGS Invokana (Invokamet) is a relatively new SGLT2 inhibitor diabetes drug that is intended to be used
Sheller_PhiladelphiaLife_Small170x170

Screenshot 2015-05-06 18.57.36

The attorneys at Sheller P.C. have been recognized again this year as SuperLawyers. For the twelfth consecutive year, founder Stephen A. Sheller has been selected by the organization and specifically honored as one of the Top

The Wall Street Journal 2013-07-26 The Wall Street Journal today published a front page story on the Department of Justice investigation into fraud in physician-owned distributorships of medical devices. Some instances of this

Pharmalot.com, Pharmaceutical Industry News 2013-07-11 In an unusual tactic, an attorney is prodding the FDA to seek documents that purportedly detail side effects caused by the Risperdal antipsychotic, but cannot be released publicly

The Philadelphia Inquirer & “Fierce Pharma” 2013-07-10 The U.S. Food and Drug Administration is dragging its feet in addressing concerns that Johnson & Johnson’s antipsychotic drugs Risperdal and Invega are dangerous, a Philadelphia